PT  - JOURNAL ARTICLE
AU  - Dan-Yu Lin
AU  - Donglin Zeng
AU  - Yu Gu
AU  - Thomas R Fleming
AU  - Philip R Krause
TI  - Reliably Assessing Duration of Protection for COVID-19 Vaccines
AID  - 10.1101/2021.12.22.21268201
DP  - 2021 Jan 01
TA  - medRxiv
PG  - 2021.12.22.21268201
4099  - http://medrxiv.org/content/early/2021/12/27/2021.12.22.21268201.short
4100  - http://medrxiv.org/content/early/2021/12/27/2021.12.22.21268201.full
AB  - Decision-making about booster dosing for COVID-19 vaccine recipients hinges on reliable methods for evaluating the longevity of vaccine protection. We show that modeling of protection as a piecewise linear function of time since vaccination for the log hazard ratio of the vaccine effect provides more reliable estimates of vaccine effectiveness at the end of an observation period and also more reliably detects plateaus in protective effectiveness as compared with the traditional method of estimating a constant vaccine effect over each time period. This approach will be useful for analyzing data pertaining to COVID-19 vaccines and other vaccines where rapid and reliable understanding of vaccine effectiveness over time is desired.Competing Interest StatementThe authors have declared no competing interest.Funding StatementNational Institutes of Health grant R01 AI029168Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesI confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThere are no actual data in this manuscript